News - Biotechnology
Australia’s IP trends reveal post-pandemic innovation shift
Australia’s life sciences sector continues to evolve amidst a dynamic landscape of intellectual property (IP) rights, particularly patents, which are […]
MoreNews - Biotechnology
CSL reshapes R&D while bracing for U.S. tariffs
Australia’s largest biotech company CSL is streamlining its R&D operations to enhance efficiency amidst a rapidly evolving global landscape. The […]
MoreNews - Biotechnology
National push to tackle cardiovascular and diabetes burden backs Aussie start-ups
Fourteen biotech and medtech innovators will share in a $12 million funding injection aimed at fast-tracking life-changing solutions for people […]
MoreNews - Biotechnology
Aussie-invented smart capsule wins regulatory nod
An ingestible gas-sensing capsule originally developed at RMIT University has received regulatory clearance from the U.S. Food and Drug Administration […]
MoreNews - Biotechnology
QBiotics reports promising data in rare cancer trial
On Rare Cancers Awareness Day (26 June), Australian biotech QBiotics Group unveiled the final efficacy and safety results from stage […]
MoreNews - Biotechnology
AusBiotech champions Australia’s momentum in the global life sciences race
AusBiotech has wrapped up a week packed with bilateral and multilateral engagements at the BIO International Convention 2025 in Boston. […]
MoreNews - Biotechnology
Local biotech earns green light to manufacture next-gen cell therapies
A Melbourne-based biotech company has secured a stem cell manufacturing licence from the Therapeutic Goods Administration (TGA), a move that […]
MoreNews - Biotechnology
NRF backs local ophthalmic biotech
A Melbourne-based biotechnology company has landed a game-changing investment to push forward its novel glaucoma implant to address the long-standing […]
MoreNews - Biotechnology
Purpose, policy and the future of clinical trials: Noxopharm CEO on what’s next for Australian biotech
As the world marks Clinical Trials Day (20 May), Dr Gisela Mautner, CEO of ASX-listed biotech Noxopharm, brings a bold […]
MoreNews - Biotechnology
World-first trial 3D prints skin directly onto wounds using robotic technology
In a world-first clinical trial, a robot developed by an Australian biotech company is being used to 3D print human […]
MoreRecent Posts in Pharma, MedTech & Biotech
Health Minister claims no knowledge of patients dying while waiting to access new medicines
August 8, 2025
in News - Pharmaceuticals
$30M research zeroes in on breast cancer’s lethal second act
August 8, 2025
in Medical and Science
Australia among global firsts in shoulder replacement with new Stryker robotics system
August 8, 2025
in News - MedTech & Diagnostics
Wet AMD trials miss the mark while biosimilar battlelines form
August 7, 2025
in News - Pharmaceuticals
Kidney disease hiding in plain sight in General Practice
August 7, 2025
in News - Pharmaceuticals
Liquid biopsy out of reach for lung cancer patients despite clinical demand
August 7, 2025
in News - MedTech & Diagnostics
Minister Butler rewrites the playbook with unconventional Chief of Staff appointment
August 6, 2025
in News - Pharmaceuticals
What Philips’ new report adds to the ‘AI in healthcare’ debate
August 6, 2025
in News - MedTech & Diagnostics
Follow Us
Partner with us
News - Pharmaceuticals
Health Minister claims no knowledge of patients dying while waiting to access new medicines
Federal Minister for Health, Ageing and Disability, Mark Butler, has acknowledged the explosive pace of innovation, calling it a “turbocharged […]
MoreMedical and Science
$30M research zeroes in on breast cancer’s lethal second act
In a landmark investment to reduce deaths from recurrent early breast cancer, the National Breast Cancer Foundation (NBCF) has awarded […]
MoreNews - MedTech & Diagnostics
Australia among global firsts in shoulder replacement with new Stryker robotics system
Robotic-assisted surgery is well established in hip and knee arthroplasty, but its role in shoulder surgery is still in its […]
MoreNews - Pharmaceuticals
Wet AMD trials miss the mark while biosimilar battlelines form
Patient outcomes in neovascular (wet) age-related macular degeneration (nAMD) did not see improvement despite the addition of a multitargeted trap […]
More